Completed PHASE3 INTERVENTIONAL NCT00380822

Double-Blind Study of Miglitol in Japanese With type2 Diabetes

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.

Interventions miglitol

Updated 6 times since 2017 Last updated: Sep 25, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00380822, this PHASE3 trial focuses on Type 2 Diabetes Mellitus and remains completed. Sponsored by Sanwa Kagaku Kenkyusho Co., Ltd., it has been updated 6 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanwa Kagaku Kenkyusho Co., Ltd.

Data source: Sanwa Kagaku Kenkyusho Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aichi, Japan , Chiba, Japan , Fukuoka, Japan , Gunma, Japan , Hiroshima, Japan , Hyōgo, Japan , Ibaraki, Japan , Ishikawa, Japan , Kumamoto, Japan , Kyoto, Japan and 17 more locations